Gary Walsh

Pharmaceutical Biotechnology (eBook, ePUB)

Concepts and Applications

• Format: ePub

Produktbeschreibung

Pharmaceutical Biotechnology offers students taking Pharmacy and related Medical and Pharmaceutical courses a comprehensive introduction to the fast-moving area of biopharmaceuticals. With a particular focus on the subject taken from a pharmaceutical perspective, initial chapters offer a broad introduction to protein science and recombinant DNA technology- key areas that underpin the whole subject. Subsequent chapters focus upon the development, production and analysis of these substances. Finally the book moves on to explore the science, biotechnology and medical applications of specific biotech products categories. These include not only protein-based substances but also nucleic acid and cell-based products. * introduces essential principles underlining modern biotechnology- recombinant DNA technology and protein science * an invaluable introduction to this fast-moving subject aimed specifically at pharmacy and medical students * includes specific 'product category chapters' focusing on the pharmaceutical, medical and therapeutic properties of numerous biopharmaceutical products. * entire chapter devoted to the principles of genetic engineering and how these drugs are developed. * includes numerous relevant case studies to enhance student understanding * no prior knowledge of protein structure is assumed

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: John Wiley & Sons
• Seitenzahl: 504
• Erscheinungstermin: 25. April 2013
• Englisch
• ISBN-13: 9781118685754
• Artikelnr.: 38402310

Autorenporträt

Dr Gary Walsh, Chemical and Environmental Science Department, University of Limerick, Republic of Ireland.

Inhaltsangabe

Preface. Acronyms. 1 Pharmaceuticals, biologics and biopharmaceuticals. 1.1
Introduction to pharmaceutical products. 1.2 Biopharmaceuticals and
pharmaceutical biotechnology. 1.3 History of the pharmaceutical industry.
1.4 The age of biopharmaceuticals. 1.5 Biopharmaceuticals: current status
and future prospects. 2 Protein structure. 2.1 Introduction. 2.2 Overview
of protein structure. 2.3 Higher level structure. 2.4 Protein stability and
folding. 2.5 Protein post-translational modifi cation. 3 Gene manipulation
and recombinant DNA technology. 3.1 Introduction. 3.2 Nucleic acids:
function and structure. 3.3 Recombinant production of therapeutic proteins.
3.4 Classical gene cloning and identifi cation. 4 The drug development
process. 4.1 Introduction. 4.2 Discovery of biopharmaceuticals. 4.3 The
impact of genomics and related technologies upon drug discovery. 4.4 Gene
chips. 4.5 Proteomics. 4.6 Structural genomics. 4.7 Pharmacogenetics. 4.8
Initial product characterization. 4.9 Patenting. 4.10 Delivery of
biopharmaceuticals. 4.10.3 Nasal, transmucosal and transdermal delivery
systems. 4.11 Preclinical studies. 4.12 Pharmacokinetics and
pharmacodynamics. 4.13 Toxicity studies. 4.14 The role and remit of
regulatory authorities. 4.15 Conclusion. 5 Sources and upstream processing.
5.1 Introduction. 5.2 Sources of biopharmaceuticals. 5.3 Upstream
processing. 6 Downstream processing. 6.1 Introduction. 6.2 Initial product
recovery. 6.3 Cell disruption. 6.4 Removal of nucleic acid. 6.5 Initial
product concentration. 6.6 Chromatographic purifi cation. 6.7
High-performance liquid chromatography of proteins. 6.8 Purifi cation of
recombinant proteins. 6.9 Final product formulation. 7 Product analysis.
7.1 Introduction. 7.2 Protein-based contaminants. 7.3 Removal of altered
forms of the protein of interest from the product stream. 7.4 Detection of
protein-based product impurities. 7.5 Immunological approaches to detection
of contaminants. 7.6 Endotoxin and other pyrogenic contaminants. 8 The
cytokines: The interferon family. 8.1 Cytokines. 8.1.1 Cytokine receptors.
8.1.2 Cytokines as biopharmaceuticals. 8.2 The interferons. 8.3 Interferon
biotechnology. 8.4 Conclusion. 9 Cytokines: Interleukins and tumour
necrosis factor. 9.1 Introduction. 9.2 Interleukin-2. 9.3 Interleukin-1.
9.4 Interleukin-11. 9.5 Tumour necrosis factors. 10 Growth factors. 10.1
Introduction. 10.2 Haematopoietic growth factors. 10.3 Growth factors and
wound healing. 11 Therapeutic hormones. 11.1 Introduction. 11.2 Insulin.
11.3 Glucagon. 11.4 Human growth hormone. 11.5 The gonadotrophins. 11.6
Medical and veterinary applications of gonadotrophins. 11.7 Additional
recombinant hormones now approved. 11.8 Conclusion. 12 Recombinant blood
products and therapeutic enzymes. 12.1 Introduction. 12.2 Haemostasis. 12.3
Anticoagulants. 12.4 Thrombolytic agents. 12.5 Enzymes of therapeutic
value. 13 Antibodies, vaccines and adjuvants. 13.1 Introduction. 13.2
Traditional polyclonal antibody preparations. 13.3 Monoclonal antibodies.
13.4 Vaccine technology. 13.5 Adjuvant technology. 14 Nucleic-acid- and
cell-based therapeutics. 14.1 Introduction. 14.2 Gene therapy. 14.3 Vectors
used in gene therapy. 14.4 Gene therapy and genetic disease. 14.5 Gene
therapy and cancer. 14.6 Gene therapy and AIDS. 14.7 Antisense technology.
14.8 Oligonucleotide pharmacokinetics and delivery. 14.9 Aptamers. 14.10
Cell- and tissue-based therapies. 14.11 Conclusion. Index.